Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03386526
Title APG-1387 in Patients With Advanced Solid Tumors or Hematologic Malignancies
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Ascentage Pharma Group Inc.
Indications

Advanced Solid Tumor

hematologic cancer

Therapies

APG-1387

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.